Comparative studies with exendin(9-39)amide and the novel (Pro(3))GIP receptor antagonist indicates that glucose-dependent insulinotropic polypeptide is the major hormone of the enteroinsular axis

Finbarr O'Harte, Victor Gault, P Harriott, BD Green, Peter Flatt

Research output: Contribution to journalArticle

LanguageEnglish
Pages548
JournalDiabetologia
Volume45
Issue numberSuppl.
Publication statusPublished - Aug 2002

Cite this

@article{ddaac30e8a7c4e48b2e4b6d108574751,
title = "Comparative studies with exendin(9-39)amide and the novel (Pro(3))GIP receptor antagonist indicates that glucose-dependent insulinotropic polypeptide is the major hormone of the enteroinsular axis",
author = "Finbarr O'Harte and Victor Gault and P Harriott and BD Green and Peter Flatt",
note = "38th EASD Annual Meeting of the European-Association-for-the-Study-of-Diabetes, BUDAPEST, HUNGARY, SEP 01-05, 2002",
year = "2002",
month = "8",
language = "English",
volume = "45",
pages = "548",
journal = "Diabetologia",
issn = "0012-186X",
number = "Suppl.",

}

TY - JOUR

T1 - Comparative studies with exendin(9-39)amide and the novel (Pro(3))GIP receptor antagonist indicates that glucose-dependent insulinotropic polypeptide is the major hormone of the enteroinsular axis

AU - O'Harte, Finbarr

AU - Gault, Victor

AU - Harriott, P

AU - Green, BD

AU - Flatt, Peter

N1 - 38th EASD Annual Meeting of the European-Association-for-the-Study-of-Diabetes, BUDAPEST, HUNGARY, SEP 01-05, 2002

PY - 2002/8

Y1 - 2002/8

M3 - Article

VL - 45

SP - 548

JO - Diabetologia

T2 - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - Suppl.

ER -